Investigation of efficacy of different spinal cord stimulation paradigms for the treatment of chronic neuropathic pain - PARS

niversitätsklinikum Heidelberg0 个研究点目标入组 60 人开始时间: 2020年1月14日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients suffering from intractable neuropathic pain, who have been considered for SCS therapy according to current German treatment guidelines and, within 48 of study enrolment, were already implanted with a wireless SCS device (Stimwave®)
•Placement of the distal tip of the electrode between upper level of Th8 and lower level of Th12
•leg pain > back pain
•age of patient = 18 Jahre
•Written consent
•Duration of pain history >6 months and < 5 years

•Covering of the pain area with the SCS stimulation device (Stimwave®) <90%
•Ischemic pain (i.e. Peripheral artery disease, angioma)
•Chronic primary pain
•Implantation of several SCS electrodes
•Coagulopathy
•Any planned changes in existing pain medication for the duration of trial participation (period of 35 days)
•Pregnancy
•Neurodegenerative disease
•Lack of understanding of the trial and the individual consequences of participating in the trial
•Expected lack of compliance (i.e. patient is not able to complete the trial questionnaires)

发起方

niversitätsklinikum Heidelberg